Bacterial infections: rapid & reliable pathogen detection

Rapid detection of diseases is crucial to prevent health crises, as diagnostics face delays.

Bacterial infections: <span>rapid & reliable</span> pathogen detection

Overview

Nucleotica enables rapid pathogen detection, empowering swift responses to diseases and improving health.

Infectious diseases remain a persistent global challenge, responsible for millions of deaths each year and placing heavy burden on global health systems and economies. The rapid detection and containment of infectious agents are critical to managing outbreaks and preventing widespread health crises.

However, traditional diagnostic methods often require centralized laboratories, sophisticated equipment, and long turnaround times, delaying interventions and potentially worsening outcomes.

Rapid on-site testing.

Portable design.

The compact, lightweight system is designed for use in diverse settings, from urban clinics to remote locations.

Fast results.

Delivers results in just 30 minutes, enabling healthcare providers to make timely decisions during critical moments.

Ease of use.

Requires minimal training and no specialized infrastructure, making it accessible to non-expert operators.

Wide pathogen detection.

Comprehensive panels.

The platform can detect a broad spectrum of infectious agents, including bacteria, protozoa, fungi, helminths and more.

Emerging pathogens.

Adaptable for new and evolving threats, such as emerging strain variations and emerging pathogens, ensuring preparedness for future pandemics.

High sensitivity.

Detects pathogens even in extremely low concentrations, ensuring accurate results regardless of sample quality.

High resistance to inhibitors and low sample volumes requirements.

Unlike traditional PCR methods.

The Nucleotica system remains reliable even in challenging conditions, making it valuable for field samples.

Min sample, max ease.

Requires only small quantities of sample material (e.g., saliva, blood, or environmental swabs), making it less invasive for patients and easier to collect.

Scalability and flexibility.

Custom panels.

The platform supports the fast and inexpensive creation of customized detection panels tailored to specific outbreaks or regional needs.

Upgradable system.

Future software and hardware updates ensure continued adaptability to new pathogens and diagnostic advancements.

Impact on Healthcare

Nucleotica can transform diagnostics of infection deseases.

Accelerating interventions.

Early Detection: Rapid pathogen detection enables early treatment and containment, reducing the spread of infectious diseases.

Timely Decision-Making: Real-time results provide actionable insights, allowing healthcare providers to start treatments immediately or implement quarantine measures effectively.

Improving patient outcomes.

Accurate Diagnoses: High sensitivity and specificity ensure that patients receive appropriate treatments without delay.

Reducing Morbidity and Mortality: Early interventions lead to better outcomes, especially in severe or life-threatening infections.

Supporting public health efforts.

Outbreak Management: By detecting pathogens on-site, the platform aids in identifying and managing outbreaks quickly, preventing wider spread.

Global Health Applications: The platform's portability and affordability make it ideal for resource-limited settings with scarce access to diagnostics.

Applications

Our solution enables efficient diagnostics, enhancing care in various settings.

Urban healthcare facilities.

Efficiently diagnose bacterial infections in busy clinics and hospitals, reducing wait times and improving patient throughput.

Remote and field settings.

Ideal for field epidemiology, disaster response, and remote clinics, enabling diagnostics in areas without laboratory infrastructure.

Outbreak response.

Supports rapid deployment in response to disease outbreaks, ensuring containment measures are implemented as soon as possible.

Global health initiatives.

Facilitates widespread testing in underserved regions, contributing to global efforts in combating infectious diseases like tuberculosis, malaria, and toxoplasmosis.

Nucleotica

Why choose the Nucleotica platform for infectious sisease diagnostics?

Speed and efficiency.

Provides fast results in less than 30 minutes, enabling swift action during outbreaks or critical health emergencies.

Portability.

Compact design allows diagnostics in virtually any environment, from hospitals to remote field locations.

Versatility.

Identifies a wide range of pathogens, including emerging threats, ensuring preparedness for future health challenges.

Cost-effective.

Reduces the need for expensive infrastructure and long-distance sample transport, making advanced diagnostics more affordable.

Proven reliability.

High sensitivity and resistance to inhibitors ensure accurate results even in challenging sample conditions.

Contact us

Reach out to start your next innovation today.